We and others have found that increased osteoprotegerin concentrations independently predict coronary atherosclerosis, endothelial activation, carotid atherosclerosis and cardiovascular disease [14,21,22]. This evidence concerns the gene TNFRSF11B and coronary atherosclerosis.